Article
Epigenetics in prostate cancer: clinical implications
15 Jun 2021
Abstract excerpt
Epigenetic alterations, including changes in DNA methylation, histone modifications and nucleosome remodeling, result in abnormal gene expression patterns that contribute to prostate tumor initiation and continue to evolve during the course of disease progression. Epigenetic modifications are responsible for silencing tumor-suppressor genes, activating oncogenic drivers, and driving therapy resistance and thus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
